Vimarsana
Biggest News Aggregation in the World

Page 7 - Nasdaq Coll News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nasdaq Coll. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nasdaq Coll Today - Breaking & Trending Today

ObsEva (NASDAQ:OBSV) and Collegium Pharmaceutical (NASDAQ:COLL) Critical Survey - Vimarsana News

ObsEva (NASDAQ:OBSV) and Collegium Pharmaceutical (NASDAQ:COLL) Critical Survey

Collegium Pharmaceutical (NASDAQ:COLL – Get Rating) and ObsEva (NASDAQ:OBSV – Get Rating) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, analyst recommendations, profitability, earnings, dividends, risk and institutional ownership. Risk & Volatility Collegium Pharmaceutical has a beta of 0.81, […]

Collegium Pharmaceutical (NASDAQ:COLL) Lifted to "Buy" at StockNews.com - Vimarsana News

Collegium Pharmaceutical (NASDAQ:COLL) Lifted to "Buy" at StockNews.com

StockNews.com upgraded shares of Collegium Pharmaceutical (NASDAQ:COLL – Get Rating) from a hold rating to a buy rating in a research note issued to investors on Saturday morning. A number of other equities analysts have also recently issued reports on COLL. Piper Sandler dropped their price objective on Collegium Pharmaceutical from $37.00 to $35.00 in […]

Martingale Asset Management L P Has $653,000 Position in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - Vimarsana News

Martingale Asset Management L P Has $653,000 Position in Collegium Pharmaceutical, Inc. (NASDAQ:COLL)

Martingale Asset Management L P raised its position in Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Get Rating) by 15.9% in the fourth quarter, HoldingsChannel.com reports. The fund owned 28,168 shares of the specialty pharmaceutical company’s stock after purchasing an additional 3,855 shares during the quarter. Martingale Asset Management L P’s holdings in Collegium Pharmaceutical were worth […]

Collegium Pharmaceutical (NASDAQ:COLL) Trading Down 2.8% Following Insider Selling - Vimarsana News

Collegium Pharmaceutical (NASDAQ:COLL) Trading Down 2.8% Following Insider Selling

Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Get Rating) traded down 2.8% on Friday after an insider sold shares in the company. The company traded as low as $21.72 and last traded at $21.72. 19,418 shares changed hands during mid-day trading, a decline of 95% from the average session volume of 429,588 shares. The stock had previously […]

Collegium Pharmaceutical, Inc. (NASDAQ:COLL) CEO Sells $684,834.90 in Stock - Vimarsana News

Collegium Pharmaceutical, Inc. (NASDAQ:COLL) CEO Sells $684,834.90 in Stock

Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Get Rating) CEO Joseph Ciaffoni sold 31,271 shares of the business’s stock in a transaction on Tuesday, May 30th. The stock was sold at an average price of $21.90, for a total value of $684,834.90. Following the completion of the sale, the chief executive officer now directly owns 368,816 shares […]

Source: wkrb13.com